ストックスクリーナーアプリを入手
65.79
4.91%
3.0225
Kiniksa Pharmaceuticals International Plc (KNSA) 最新ニュース
Will Broad Russell Index Inclusion Reshape Kiniksa Pharmaceuticals' (KNSA) ARCALYST-Centered Growth Narrative? - simplywall.st
Performance share awards at Kiniksa (NASDAQ: KNSA) tied to KPL-387 FDA goals - Stock Titan
Kiniksa (KNSA) Chief Strategy Officer named as insider in Form 3 - Stock Titan
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month HighHere's What Happened - MarketBeat
Kiniksa Pharmaceuticals International, plc (KNSA) Is a Great Choice for 'Trend' Investors, Here's Why - Yahoo Finance
Kiniksa Pharmaceuticals International, plc (KNSA) surges 5.4%: Is this an indication of further gains? - MSN
What makes Kiniksa Pharmaceuticals International, plc (KNSA) a strong momentum stock: Buy now? - MSN
Kiniksa Pharmaceuticals Hits New 52-Week High of USD 59.89 - MarketsMojo
Kiniksa Pharmaceuticals Hits New 52-Week High of USD 63.77 - MarketsMojo
Peregrine Capital Management LLC Sells 29,550 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Inspire Investing LLC Makes New $1.70 Million Investment in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Pictet Asset Management Holding SA Sells 164,232 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
What Makes Kiniksa Pharmaceuticals International, plc (KNSA) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains? - Yahoo Finance
AMI Asset Management Corp Has $1.06 Million Stake in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International PLC (KNSA) Shares Surge 5. - GuruFocus
KNSA Maintained by Wedbush -- Price Target Raised to $72.00 - GuruFocus
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 2500 Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS: KNSA) added to Russell 2000 Index - marketscreener.com
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month High on Analyst Upgrade - MarketBeat
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 2000 Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 3000E Growth Benchmark - marketscreener.com
Kiniksa Pharmaceuticals International, plc(NasdaqGS: KNSA) added to Russell 3000E Index - marketscreener.com
Kiniksa Pharmaceuticals International (MEX:KNSAN) Cyclicall - GuruFocus
Here's why you should add Kiniksa stock to your portfolio now - MSN
Kiniksa Pharmaceuticals International, plc(NasdaqGS:KNSA) added to Russell 2000 Growth-Defensive Index - marketscreener.com
Here's Why You Should Add Kiniksa Stock to Your Portfolio Now - Yahoo Finance
KNSA Forecast — Price Target — Prediction for 2027 - TradingView
Kiniksa Pharmaceuticals International, plc Class A Actuals & Estimates (BOATS:KNSA) - TradingView
Kiniksa Pharmaceuticals International PLC (KNSA) Stock Down 3.8% but Still Overvalued -- GF Score: 56/100 - GuruFocus
Kiniksa Pharmaceuticals International, plc Class A Actuals & Estimates (BMV:KNSA/N) - TradingView
Kiniksa Pharmaceuticals International, plc Class A Actuals & Estimates (BIVA:KNSA/N) - TradingView
KNSA/N Forecast — Price Target — Prediction for 2027 - TradingView
Kiniksa Pharmaceuticals International Plc (NASDAQ:KNSA) Presents a Compelling GARP Opportunity - ChartMill
US High Growth Tech Stocks to Watch - simplywall.st
Kiniksa Pharmaceuticals International, plc $KNSA Shares Bought by SG Americas Securities LLC - MarketBeat
Kiniksa Pharmaceuticals lifts revenue outlook, shares near record high - AD HOC NEWS
Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 52-Week HighTime to Buy? - MarketBeat
Is Kiniksa Pharmaceuticals International PLC (KNSA) Overvalued A - GuruFocus
Here's why momentum in Kiniksa Pharmaceuticals International, plc (KNSA) should keep going - MSN
Kiniksa Pharmaceuticals International, plc (KNSA) upgraded to strong buy: Here's what you should know - MSN
Here's Why Momentum in Kiniksa Pharmaceuticals International, plc (KNSA) Should Keep going - Yahoo Finance
Kiniksa Pharmaceuticals International PLC - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kiniksa Pharmaceuticals International PLC (KNSA) Institutional Confidence - TradingKey
Granahan Investment Management LLC Buys 32,642 Shares of Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Kiniksa Pharmaceuticals International, plc (KNSA) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Spruce Street Capital LP Purchases New Position in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
KNSA Q1 2026 Earnings: EPS Surges Past Estimates, Stock Edges HigherEBITDA Estimate Trend - newsline.com
KNSA Q1 2026 Earnings: EPS Surges Past Estimates, Stock Edges UpEarnings Revision Downgrade - newsline.com
Kiniksa Pharmaceuticals Q1 2026 Earnings: EPS Surpasses Estimates by Over 31%Earnings Growth Analysis - newsline.com
Castleark Management LLC Raises Stock Holdings in Kiniksa Pharmaceuticals International, plc $KNSA - MarketBeat
KNSA: Record ARCALYST growth, robust pipeline, and key clinical catalysts drive future momentum - TradingView
Kiniksa Pharmaceuticals (KNSA) Edges Lower, Testing Key Support LevelsZero Gamma Level - newsline.com
ESSEX INVESTMENT MANAGEMENT CO LLC's Kiniksa Pharmaceuticals International PLC(KNSA) Holding History - GuruFocus
0.17%
1.83%
大文字化:
|
ボリューム (24 時間):